German enzyme therapy targets autoimmune disorders, reducing the need for side-effect laden drugs
February 1, 2001 – German enzyme therapy targets autoimmune disorders, reducing the need for side-effect laden drugs In autoimmune diseases like rheumatoid arthritis, lupus, and MS, the immune system goes “haywire.” Instead of serving its normal protective function, it produces abnormally high levels of antibodies called circulating immune complexes (CICs). In a healthy person,... Read More >


